This company develops a quantitative diagnostic platform for rapid, point-of-care identification of multiple pathogens in various clinical samples. The technology delivers results in under 15 minutes, enabling clinicians to quickly determine the specific virus, bacteria, or fungus causing an infection. This rapid, low-cost testing supports targeted antimicrobial stewardship and reduces inappropriate broad-spectrum antibiotic use.
Funding
Funding not disclosed
Founders
Product
Problem
Current diagnostic methods for respiratory infections often struggle to quickly and accurately differentiate between viral, bacterial, and fungal pathogens, leading to inappropriate antibiotic prescriptions and delayed treatment. Broad-spectrum antibiotic use contributes to antimicrobial resistance, while the inability to identify specific pathogens can result in hospitalizations and increased healthcare costs.
Solution
Oxbridge Clinical is developing a point-of-care diagnostic platform that utilizes solid-state nanopore technology to quantitatively detect and differentiate between over 50 types of viruses, bacteria, and fungi from a single sample. The system is designed for use with various sample types, including respiratory swabs, blood, urine, saliva, and stool. The platform aims to provide results in under 15 minutes, enabling clinicians to make informed treatment decisions and reduce the overuse of broad-spectrum antibiotics. The device is intended to be compact and easy to use, requiring no specialized laboratory equipment.
Target Audience
The primary target audience includes healthcare professionals in primary care settings, hospitals, and clinics who require rapid and accurate diagnostic information for respiratory infections.
Features
- Solid-state nanopore technology for pathogen detection
- Customizable panel capable of identifying over 50 different microorganisms
- Compatible with multiple sample types (respiratory swab, blood, urine, saliva, stool)
- Rapid results available in under 15 minutes
- Point-of-care system designed for on-site use without specialized lab equipment
- Quantitative analysis providing specific pathogen identification
- Cost-effective consumables, targeting a price point of less than $50 per test